Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Bristol Myers Squibb CO Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $3.31 Billion
- Q1 2024
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 14,492 shares of BMY stock, worth $574,752. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,492
Previous 13,838
4.73%
Holding current value
$574,752
Previous $710,000
10.56%
% of portfolio
0.02%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.38 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.45 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.63 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.52 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.78 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $84.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...